The Importance of Prenatal Whole-Exome Sequencing Testing in the Romanian Population
Authors:
- Ileana-Delia SăbăuISIleana-Delia Săbău
- Laurentiu-Camil BohîlteaLBLaurentiu-Camil Bohîltea
- Viorica Elena RădoiVRViorica Elena Rădoi
- Anca Mirela BardanABAnca Mirela Bardan
- Ovidiu Virgil MaioruOMOvidiu Virgil Maioru
- Mihaela ȚurcanMȚMihaela Țurcan
- Viorel Aurel Suciu-LazarVSViorel Aurel Suciu-Lazar
- Iuliana CeausuIuliana Ceausu
Open Access
- 14 March 2025
- journal article
- research article
- Published by MDPI AG in Journal of Mind and Medical Sciences
- Vol. 12 (1) , 7
Abstract
One major cause of prenatal mortality and morbidity is congenital abnormalities. Knowing the prevalence and etiology of congenital malformations is essential for analyzing trends and improving neonatal care. Objective: the team aimed to evaluate the utility of whole-exome sequencing (WES) in Romanian prenatal care, highlighting its diagnostic efficacy in comparison to molecular karyotyping, particularly in cases with negative genetic results prior to WES, unfavorable pregnancy outcomes, and consanguinity. Methods: Initially, we identified pregnancies with abnormal ultrasounds unrelated to known syndromes. Subsequently, we performed SNP (single nucleotide polymorphism)-array testing, yielding negative results. We then applied prenatal WES, utilizing Massive Parallel Sequencing on the NovaSeq 6000 platform (average coverage > 100× read length: 2 × 100 bp) with library preparation using the Twist Human Core Exome kit RefSeq & Mitochondrial panel (Twist Bioscience). The bioinformatic analysis involved direct comparison to the human reference sequence (hg38). Results: We achieved a 50% diagnostic rate. After receiving results, two couples chose pregnancy termination, five had uneventful births, and one pregnancy ended in stillbirth. Additionally, we identified three incidental findings that enhanced patient and at-risk member management. This article details ten prenatal cases tested with WES, highlighting its superior diagnostic performance compared to the SNP array. WES detected the genetic diagnostic in 50% of cases that the SNP array did not. We emphasize the advantages of WES in prenatal diagnostics while acknowledging the need for further investigations to comprehensively evaluate its diagnostic utility in the Romanian population.Keywords
This publication has 36 references indexed in Scilit:
- Comprehensive prenatal diagnostics: Exome versus genome sequencingPrenatal Diagnosis, 2023
- Diagnostic yield of exome sequencing for prenatal diagnosis of fetal structural anomalies: A systematic review and meta‐analysisPrenatal Diagnosis, 2022
- Whole-exome sequencing increases the diagnostic rate for prenatal fetal structural anomaliesEuropean Journal of Medical Genetics, 2021
- Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and MelanomaJAMA, 2020
- Diagnosis of fetal non‐chromosomal abnormalities on routine ultrasound examination at 11–13 weeks' gestationUltrasound in Obstetrics & Gynecology, 2019
- Fetal exome sequencing: yield and limitations in a tertiary referral centerUltrasound in Obstetrics & Gynecology, 2019
- Exome sequencing in syndromic brain malformations identifies novel mutations in ACTB, and SLC9A6, and suggests BAZ1A as a new candidate geneBirth Defects Research, 2018
- Joint Position Statement from the International Society for Prenatal Diagnosis (ISPD), the Society for Maternal Fetal Medicine (SMFM), and the Perinatal Quality Foundation (PQF) on the use of genome‐wide sequencing for fetal diagnosisPrenatal Diagnosis, 2018
- Promises, pitfalls and practicalities of prenatal whole exome sequencingPrenatal Diagnosis, 2017
- The clinical utility of microarray technologies applied to prenatal cytogenetics in the presence of a normal conventional karyotype: a review of the literaturePrenatal Diagnosis, 2013